BioVie (BIVI) has provided an update.
BioVie Inc. has successfully closed its public offering, raising $21 million through the sale of shares and warrants, with the intention of using these funds for working capital and general corporate purposes. The offering involved 15 million shares and additional warrants, while an existing warrant’s exercise price was adjusted due to the new share price established in the offering. This financial move is part of the company’s strategy to strengthen its capital structure, although it comes with the usual caveats of forward-looking statements, acknowledging the inherent risks and uncertainties in the market.
Learn more about BIVI stock on TipRanks’ Stock Analysis page.